AMGN vs COUR · P/E 24, rev $10.05B vs rev $494.3M
Amgen Inc (AMGN) versus Coursera Inc (COUR) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Coursera Inc (COUR) is a education & training services company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported COUR revenue for 2026-06-30 was $494.3M. Net income was -$100.9M. COUR currently screens at market cap $1.35B.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. COUR currently screens at market cap $1.35B.
Not investment advice. Open the AMGN and COUR stock pages for the full models.
Not investment advice.